CSIR-Centre for Cellular and Molecular Biology director Vinay Nandicoori observed that the number of animals used for bringing a single drug into human trials is alarmingly high and hoped that labs would start adopting predictive human model systems soon to prevent this.
He was addressing a conclave organised by the Atal Incubation Centre - (AIC-CCMB)’s Centre for Predictive Human Model Systems (CPHMS) recently with representatives of the scientific community and biotech industries, specifically contract research organisations (CROs), to discuss reducing animal testing for human drug development.
A leading authority on non-animal methodologies and All India Institute of Medical Sciences (AIIMS-Jammu) academic Dr. Y.K. Gupta said, “No regulatory body will allow drugs for human usage unless they are tested on animals. We need to provide robust, clinically proven alternatives to animal testing before we ask regulators, scientists and the pharma industry to stop using animal toxicology models.”
